March 27 (Reuters) - Neuronetics Inc STIM.O:
NEURONETICS: SOME NON-CASH REVISIONS MADE TO FINANCIAL STATEMENTS RELATED TO CO'S ACQUISITION OF GREENBROOK TMS & SHARES OUTSTANDING IN Q4
NEURONETICS: UPDATED Q4 LOSS PER SHARE $0.34
NEURONETICS: UPDATED Q4 OPERATING EXPENSES $26.4 MILLION
Source text: ID:nGNX2cP9GY
Further company coverage: STIM.O
((Reuters.Briefs@thomsonreuters.com;))